176 related articles for article (PubMed ID: 8717356)
1. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909.
Sivam SP
Brain Res Mol Brain Res; 1996 Jan; 35(1-2):197-210. PubMed ID: 8717356
[TBL] [Abstract][Full Text] [Related]
2. Locomotor-activity-induced changes in striatal levels of preprotachykinin and preproenkephalin mRNA. Regulation by the dopaminergic and glutamatergic systems.
Liste I; Rodriguez-Pallares J; Caruncho HJ; Labandeira-Garcia JL
Brain Res Mol Brain Res; 1999 Jun; 70(1):74-83. PubMed ID: 10381545
[TBL] [Abstract][Full Text] [Related]
3. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
Sivam SP
J Pharmacol Exp Ther; 1989 Sep; 250(3):818-24. PubMed ID: 2476548
[TBL] [Abstract][Full Text] [Related]
4. GBR-12909-induced self-injurious behavior: role of dopamine.
Sivam SP
Brain Res; 1995 Sep; 690(2):259-63. PubMed ID: 8535847
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
Cenci MA; Campbell K; Björklund A
Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
[TBL] [Abstract][Full Text] [Related]
6. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
Basura GJ; Walker PD
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):66-77. PubMed ID: 11483243
[TBL] [Abstract][Full Text] [Related]
7. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
Sivam SP
Neuropeptides; 1993 Jul; 25(1):35-45. PubMed ID: 7692341
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.
Gresch PJ; Walker PD
Brain Res Mol Brain Res; 1999 Jun; 70(1):125-34. PubMed ID: 10381550
[TBL] [Abstract][Full Text] [Related]
9. Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion.
Granata R; Wenning GK; Jolkkonen J; Jenner P; Marsden CD
J Neural Transm (Vienna); 1996; 103(3):249-60. PubMed ID: 8739837
[TBL] [Abstract][Full Text] [Related]
10. Regulation of striatonigral prodynorphin peptides by dopaminergic agents.
Trujillo KA; Day R; Akil H
Brain Res; 1990 Jun; 518(1-2):244-56. PubMed ID: 1975215
[TBL] [Abstract][Full Text] [Related]
11. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
Sivam SP
Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560
[TBL] [Abstract][Full Text] [Related]
12. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
Bronstein DM; Ye H; Pennypacker KR; Hudson PM; Hong JS
Brain Res Mol Brain Res; 1994 May; 23(3):191-203. PubMed ID: 7914658
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
Jiang HK; McGinty JF; Hong JS
Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
[TBL] [Abstract][Full Text] [Related]
14. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
Sivam SP; Breese GR; Krause JE; Napier TC; Mueller RA; Hong JS
J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804
[TBL] [Abstract][Full Text] [Related]
15. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum.
Li SJ; Jiang HK; Stachowiak MS; Hudson PM; Owyang V; Nanry K; Tilson HA; Hong JS
Brain Res Mol Brain Res; 1990 Aug; 8(3):219-25. PubMed ID: 1977070
[TBL] [Abstract][Full Text] [Related]
16. Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission.
Walker PD; Capodilupo JG; Wolf WA; Carlock LR
Brain Res; 1996 Sep; 732(1-2):25-35. PubMed ID: 8891265
[TBL] [Abstract][Full Text] [Related]
17. Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA.
Sivam SP; Krause JE
J Neurochem; 1992 Dec; 59(6):2278-84. PubMed ID: 1279124
[TBL] [Abstract][Full Text] [Related]
18. Time-course of changes in striatal levels of DA uptake sites, DA D2 receptor and preproenkephalin mRNAs after nigrostriatal dopaminergic denervation in the rat.
Chritin M; Feuerstein C; Savasta M
Brain Res Mol Brain Res; 1993 Sep; 19(4):318-22. PubMed ID: 8231735
[TBL] [Abstract][Full Text] [Related]
19. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
Campbell BM; Gresch PJ; Walker PD
Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
[TBL] [Abstract][Full Text] [Related]
20. Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence.
Somers DL; Beckstead RM
Brain Res Mol Brain Res; 1990 Jul; 8(2):143-58. PubMed ID: 1698246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
